New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
10:15 EDTMDCOThe Medicines Co. gaps down, levels to watch
The stock is down over 14.5% to $24.30 at time of writing, most of the loss coming in the form of a bearish gap. The move lower has sent shares to levels last seen in late 2012/early 2013 at a dip in price that later gave rise to the nearly 2-year run shares had to the upside. This nearly total retracement of gains may indicate further price weakness to come, with next support at $23.07. Resistance is at $25.35.
News For MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 5, 2015
08:37 EDTMDCOThe Medicines Co. reports Q1 Angiomax revenue down 35% to $100.7M
Subscribe for More Information
07:17 EDTMDCOThe Medicines Co. reports Q1 adjusted EPS 8c, consensus 5c
Subscribe for More Information
April 30, 2015
19:50 EDTMDCOThe Medicines Co. confirms FDA approval of Raplixa
Subscribe for More Information
19:34 EDTMDCOThe Medicines Co. announces FDA approval of Ionsys
Subscribe for More Information
17:50 EDTMDCOThe Medicines Company's Raplixa gets FDA approval
Subscribe for More Information
07:33 EDTMDCOFDA PDUFA Date for The Medicines Company's Raplixa is April 30, 2015
07:28 EDTMDCOFDA PDUFA Date for The Medicines Company's Ionsys is April 30, 2015
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use